Iris Otani, MD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address521 Parnassus Avenue, #6231
San Francisco CA 94117
Phone415-353-2725
PronounsShe/Her/Hers
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford UniversityBSBiology
    UCSD School of MedicineMD
    Santa Clara Valley Medical Center Internal Medicine ResidencyInternal Medicine
    Massachusetts General Hospital Allergy/Immunology Fellowship2016Allergy/Immunology
    University of California, San Francisco2020Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    UCSF Haile T. Debas Academy of Medical Educators2021Excellence in Teaching Award
    UCSF Health2023Exceptional Physician Award

    Collapse Overview 
    Collapse Overview
    Dr. Iris Otani is an allergist/immunologist with expertise in drug allergy and secondary hypogammaglobulinemia. She is the Medical and Quality Improvement Director for Adult Allergy/Immunology and sees patients in the UCSF Parnassus Allergy/Immunology and Drug Allergy Testing Clinics. Her academic interests also include medical education and quality improvement. She is the associate program director for the UCSF Allergy/Immunology Fellowship Training Program. She has pursued further training in quality improvement and was selected to join the Learning Health System Coach program at UCSF Health, a faculty development program for faculty who lead continuous improvement in their clinical settings. She serves on the editorial board of the Annals of Allergy Asthma & Immunology.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. From the Pages of AllergyWatch. Ann Allergy Asthma Immunol. 2024 Aug 21. Fineman SM, Otani I, Joshi SR, Chow T. PMID: 39179100.
      View in: PubMed   Mentions:    Fields:    
    2. Delayed drug reactions: The next frontier in drug allergy? Ann Allergy Asthma Immunol. 2024 Aug; 133(2):125-126. Monahan R, Otani IM. PMID: 39097346.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. From the pages of AllergyWatch. Ann Allergy Asthma Immunol. 2024 Jun 21. Fineman SM, Knox S, Hernandez-Trujillo V, Otani I. PMID: 38908433.
      View in: PubMed   Mentions:    Fields:    
    4. The shifting paradigm of gastrointestinal disease associated with antibody deficiencies. Ann Allergy Asthma Immunol. 2024 06; 132(6):669-670. Monahan R, Otani IM. PMID: 38839140.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Promoting prenatal penicillin allergy evaluations: A multi-year process improvement study. Ann Allergy Asthma Immunol. 2024 Jul; 133(1):107-109. Tsao LR, Wen S, Lamar RC, Irani RA, Otani IM. PMID: 38521341.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Rechallenges without desensitization following platinum-based chemotherapy reactions. J Oncol Pharm Pract. 2024 Apr; 30(3):572-575. Young FD, Aung S, Tang M, Anstey KM, Lee MC, Alfaro E, Cinar P, Ho H, Otani IM. PMID: 38347725.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. From the pages of AllergyWatch. Ann Allergy Asthma Immunol. 2024 Jun; 132(6):783-784. Fineman S, Lee GB, Knox S, Otani I. PMID: 38310970.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Predicting Penicillin Allergy from Patient-Reported Data: A Multi-Site Prospective Study from The United States Drug Allergy Registry. Journal of Allergy and Clinical Immunology. 2024 Feb 1; 153(2):ab228. Blumenthal BK, Ramsey RA, Phillips PE, Gonzalez-Estrada GA, Accarino AJ, Banerji BA, Stone SC, Otani OI, Khan KD, Chow CT, Liu LA, Arroyo AA, King KA, Zhang ZY. .
      View in: Publisher Site   Mentions:
    9. PEN-FAST Assessment Using Patient-Reported Reaction Histories in a Multi-Site Prospective United States Cohort. Journal of Allergy and Clinical Immunology. 2024 Feb 1; 153(2):ab241. Accarino AJ, Phillips PE, Banerji BA, Ramsey RA, Gonzalez-Estrada GA, Stone SC, Otani OI, Khan KD, Chow CT, Liu LA, Arroyo AA, King KA, Zhang ZY, Blumenthal BK. .
      View in: Publisher Site   Mentions:
    10. Evaluation of Aspirin/NSAID Hypersensitivity During Pregnancy. Journal of Allergy and Clinical Immunology. 2024 Feb 1; 153(2):ab166. Tsao TL, Li LL, Robertson RP, Irani IR, Otani OI. .
      View in: Publisher Site   Mentions:
    11. From the pages of AllergyWatch. Ann Allergy Asthma Immunol. 2024 Aug; 133(2):229-230. Fineman SM, Joshi SR, Otani I, Knox S. PMID: 38296047.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Hereditary alpha tryptasemia presenting as recurrent chemotherapy hypersensitivity reactions. Ann Allergy Asthma Immunol. 2024 03; 132(3):270-273. Monahan R, Alfaro E, Ho H, Otani IM, Tsao LR. PMID: 38151098.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    13. From the pages of AllergyWatch. Ann Allergy Asthma Immunol. 2023 Dec; 131(6):786-787. Fineman SM, Chow T, Otani I. PMID: 37827389.
      View in: PubMed   Mentions:    Fields:    
    14. United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions. J Allergy Clin Immunol. 2023 12; 152(6):1581-1586. Khan DA, Phillips EJ, Accarino JJ, Gonzalez-Estrada A, Otani IM, Ramsey A, Arroyo AC, Banerji A, Chow T, Liu AY, Stone CA, Blumenthal KG. PMID: 37652140; PMCID: PMC10872843.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Drug allergy in older adults: A study from the United States Drug Allergy Registry. Ann Allergy Asthma Immunol. 2023 11; 131(5):628-636.e2. Accarino JJO, Ramsey A, Samarakoon U, Phillips E, Gonzalez-Estrada A, Otani IM, Fu X, Banerji A, Stone CA, Khan DA, Blumenthal KG, United States Drug Allergy Registry Study Team. PMID: 37557950.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach. J Allergy Clin Immunol. 2023 08; 152(2):309-325. Greenhawt M, Dribin TE, Abrams EM, Shaker M, Chu DK, Golden DBK, Akin C, Anagnostou A, ALMuhizi F, Alqurashi W, Arkwright P, Baldwin JL, Banerji A, Bégin P, Ben-Shoshan M, Bernstein J, Bingemann TA, Bindslev-Jensen C, Blumenthal K, Byrne A, Cahill J, Cameron S, Campbell D, Campbell R, Cavender M, Chan ES, Chinthrajah S, Comberiati P, Eastman JJ, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Garvey LH, Grayson MH, Isabwe GAC, Hartog N, Hendron D, Horner CC, Hourihane JO, Iglesia E, Kan M, Kaplan B, Katelaris CH, Kim H, Kelso JM, Khan DA, Lang D, Ledford D, Levin M, Lieberman JA, Loh R, Mack DP, Mazer B, Mody K, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Nathan R, Oppenheimer J, Otani IM, Park M, Pawankar R, Perrett KP, Peter J, Phillips EJ, Picard M, Pitlick M, Ramsey A, Rasmussen TH, Rathkopf MM, Reddy H, Robertson K, Rodriguez Del Rio P, Sample S, Sheshadri A, Sheik J, Sindher SB, Spergel JM, Stone CA, Stukus D, Tang MLK, Tracy JM, Turner PJ, Vander Leek TK, Wallace DV, Wang J, Wasserman S, Weldon D, Wolfson AR, Worm M, Yacoub MR. PMID: 37295474; PMCID: PMC10247143.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use. J Allergy Clin Immunol Pract. 2023 08; 11(8):2557-2567.e6. Otani IM, Tang M, Wang L, Anstey KM, Hilts-Horeczko A, Li F, Le VP, Lee M, Bystritsky R, Mulliken JS, Wattier RL, Blumenthal KG, Doernberg SB. PMID: 37182569.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. IgG Replacement Therapy Use in Patients with Hypogammaglobulinemia after Lung Transplant. Clinical Immunology. 2023 May 1; 250:109560. Monahan MR, Perez PA, Lew LJ, Casey CM, Leard LL, Hays HS, Otani OI. .
      View in: Publisher Site   Mentions:
    19. Drug Allergy Assessments in Older Adults: A Multi-Site Prospective Study from the United States Drug Allergy Registry. Journal of Allergy and Clinical Immunology. 2023 Feb 1; 151(2):ab234. Accarino AJ, Ramsey RA, Samarakoon SU, Otani OI, Gonzalez-Estrada GA, Fu FX, Phillips PE, Stone SC, Banerji BA, Blumenthal BK. .
      View in: Publisher Site   Mentions:
    20. Access To Outpatient Chemotherapy Desensitization Improved With Implementation Of A Multidisciplinary Pharmacy, Nursing, And Allergist Team. Journal of Allergy and Clinical Immunology. 2023 Feb 1; 151(2):ab39. Monahan MR, Young YF, Alfaro AE, Legasto LC, Wang WD, Zheng ZJ, Tsao TL, Ho HH, Otani OI. .
      View in: Publisher Site   Mentions:
    21. Medicine resident perceptions regarding β-lactam antibiotic prescribing in patients with penicillin allergy. J Allergy Clin Immunol Pract. 2023 02; 11(2):638-641.e1. Jiang SY, Tang M, Desai K, Song P, Eng J, Otani IM. PMID: 36280135.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics. Ann Allergy Asthma Immunol. 2022 07; 129(1):88-94.e1. Otani IM, Tsao LR, Tang M. PMID: 35288274; PMCID: PMC8916834.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    23. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees. J Allergy Clin Immunol. 2022 05; 149(5):1525-1560. Otani IM, Lehman HK, Jongco AM, Tsao LR, Azar AE, Tarrant TK, Engel E, Walter JE, Truong TQ, Khan DA, Ballow M, Cunningham-Rundles C, Lu H, Kwan M, Barmettler S. PMID: 35176351.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    24. Direct Rechallenges, Slowed Infusions, and Titrated Infusions following Platinum Hypersensitivity Reactions: Review of 5-Year Experience. Journal of Allergy and Clinical Immunology. 2022 Feb 1; 149(2):ab173. Young YF, Anstey AK, Ho HH, Alfaro AE, Cinar CP, Otani OI. .
      View in: Publisher Site   Mentions:
    25. The United States Drug Allergy Registry: A Prospective Longitudinal Cohort Study of Patients Tested for Drug Allergies. Journal of Allergy and Clinical Immunology. 2022 Feb 1; 149(2):ab151. Blumenthal BK, Ramsey RA, Samarakoon SU, Otani OI, Gonzalez-Estrada GA, Banerji BA, Liu LA, Wickner WP, Stone SC, Park PM, Mancini MC, Judd JA, Ahola AC, Fu FX, Zhang ZY, Donelan DK, Mustafa MS, Blue BH, Sheflin SD, Harkness HT, Khan KD, Garzon-Siatoya GW, Morgenstern-Kaplan MD, Marks MM, Kerrigan KA, Rukasin RC, Phillips PE. .
      View in: Publisher Site   Mentions:
    26. Urticarial and Eczematous Eruptions Following mRNA COVID-19 Vaccination in Patients With and Without Chronic Urticaria and Atopic Dermatitis. Journal of Allergy and Clinical Immunology. 2022 Feb 1; 149(2):ab175. Shah SR, Tsao TL, Zheng ZJ, Tang TM, Otani OI. .
      View in: Publisher Site   Mentions:
    27. Implementing a Hospital-Wide Inpatient Beta-Lactam Allergy Guideline Leads to Consistent Increases in Beta-Lactam Use. Journal of Allergy and Clinical Immunology. 2022 Feb 1; 149(2):ab69. Otani OI, Tang TM, Anstey AK, Wang WL, Hilts-Horeczko HA, Li LF, Le LV, Lee LM, Mulliken MJ, Bystritsky BR, Doernberg DS. .
      View in: Publisher Site   Mentions:
    28. Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations. Clin Rev Allergy Immunol. 2022 Jun; 62(3):484-504. Anstey KM, Tsao L, Otani IM. PMID: 35031956.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. One-Bag Desensitization Protocols in the Management of Chemotherapy Hypersensitivity. J Allergy Clin Immunol Pract. 2021 11; 9(11):4055-4059. Tsao LR, Otani IM. PMID: 34749948.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. M060 SUCCESSFUL REINTRODUCTION OF MOGAMULIZUMAB VIA OUTPATIENT ONE DILUTION DESENSITIZATION PROTOCOLS FOLLOWING RECURRENT DELAYED CUTANEOUS REACTIONS. Annals of Allergy Asthma & Immunology. 2021 Nov 1; 127(5):s75. Young YF, Pincus PL, Ai AW, Otani OI. .
      View in: Publisher Site   Mentions:
    31. Perceptions Around Lung Transplant-Associated Hypogammaglobulinemia. J Clin Immunol. 2021 11; 41(8):1940-1942. Lew J, Casey M, Leard LE, Hays S, Otani IM. PMID: 34351551.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Hypersensitivity Reactions to Platinum Agents and Taxanes. Clin Rev Allergy Immunol. 2022 Jun; 62(3):432-448. Tsao LR, Young FD, Otani IM, Castells MC. PMID: 34338975; PMCID: PMC9156473.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    33. Enabling antibiotic allergy evaluations and reintroduction of first-line antibiotics for patients with cystic fibrosis. Ann Allergy Asthma Immunol. 2021 10; 127(4):456-461. Anstey KM, Choi L, Dawson D, Kleinhenz ME, Otani IM. PMID: 34048884.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    34. Impact of Rapid Transition to Telemedicine-Based Delivery on Allergy/Immunology Care During COVID-19. J Allergy Clin Immunol Pract. 2021 Jul; 9(7):2672-2679.e2. Tsao LR, Villanueva SA, Pines DA, Pham MN, Choo EM, Tang MC, Otani IM. PMID: 33894393; PMCID: PMC8061180.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    35. Screening for Severe Hypogammaglobulinemia in Lung Transplant Recipients. The Journal of Heart and Lung Transplantation. 2021 Apr 1; 40(4):s381. Otani OI, Lew LJ, Casey CM, Perez PA, Zhang ZL, Leard LL, Hays HS. .
      View in: Publisher Site   Mentions:
    36. Hypogammaglobulinemia Identification and Management in Lung Transplant Patients: Survey of Provider Practices. The Journal of Heart and Lung Transplantation. 2021 Apr 1; 40(4):s381-s382. Casey CM, Lew LJ, Hays HS, Leard LL, Otani OI. .
      View in: Publisher Site   Mentions:
    37. Perioperative use and safety of cephalosporin antibiotics in patients with documented penicillin allergy. J Allergy Clin Immunol Pract. 2021 08; 9(8):3203-3207.e1. Anstey KM, Anstey JE, Doernberg SB, Chen LL, Otani IM. PMID: 33766583.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Rapid Adoption of Video Visits and Return-to-Clinic Procedures to Maintain Access to Allergy/Immunology Care Delivery During COVID-19. Journal of Allergy and Clinical Immunology. 2021 Feb 1; 147(2):ab112. Tsao TL, Ferraris FS, Pines PD, Choo CE, Pham PM, Tang TM, Leard LL, Gross GA, Ashbaugh AC, Choi CL, Otani OI. .
      View in: Publisher Site   Mentions:
    39. Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021 Apr; 126(4):321-337. Fung M, Otani I, Pham M, Babik J. PMID: 33310180; PMCID: PMC7834857.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    40. A055 EXPANDING PENICILLIN ALLERGY EVALUATION FOR PRENATAL PATIENTS. Annals of Allergy Asthma & Immunology. 2020 Nov 1; 125(5):s10-s11. Tsao TL, Irani IR, Rosenbluth RG, Choi CL, Otani OI. .
      View in: Publisher Site   Mentions:
    41. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. J Allergy Clin Immunol Pract. 2020 10; 8(9S):S16-S116. Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ, Breslow RG, Brockow K, Buchheit KM, Cahill KN, Cernadas J, Chiriac AM, Crestani E, Demoly P, Dewachter P, Dilley M, Farmer JR, Foer D, Fried AJ, Garon SL, Giannetti MP, Hepner DL, Hong DI, Hsu JT, Kothari PH, Kyin T, Lax T, Lee MJ, Lee-Sarwar K, Liu A, Logsdon S, Louisias M, MacGinnitie A, Maciag M, Minnicozzi S, Norton AE, Otani IM, Park M, Patil S, Phillips EJ, Picard M, Platt CD, Rachid R, Rodriguez T, Romano A, Stone CA, Torres MJ, Verdú M, Wang AL, Wickner P, Wolfson AR, Wong JT, Yee C, Zhou J, Castells M. PMID: 33039007.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    42. Neurologic Conditions and Symptoms Reported Among Common Variable Immunodeficiency Patients in the USIDNET. J Clin Immunol. 2020 11; 40(8):1181-1183. Lee M, Nguyen J, Fuleihan R, Gundling K, Cunningham-Rundles C, Otani IM. PMID: 32901355; PMCID: PMC8241239.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    43. Patient Characteristics and Concerns about Drug Allergy: A Report from the United States Drug Allergy Registry. J Allergy Clin Immunol Pract. 2020 10; 8(9):2958-2967. Blumenthal KG, Harkness T, Phillips EJ, Ramsey A, Banerji A, Samarakoon U, Stone C, Fu X, Khan DA, Otani I, Camargo CA, Zhang Y, Donelan K, USDAR Study Team. PMID: 32853819.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    44. Antibiotic adverse reactions in adult cystic fibrosis patients. J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3631-3633.e1. Anstey KM, Lee M, Dawson D, Jue V, Budzik JM, Yu M, Kleinhenz ME, Otani IM. PMID: 32673878.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Novel Roles for Platinum and Taxane Agent Skin Testing in Risk Stratification of Chemotherapy Hypersensitivity. J Allergy Clin Immunol Pract. 2020 05; 8(5):1665-1667. Otani IM, Castells M. PMID: 32389278.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Development of an Antibiotic Allergy Program to Address a Clinical Gap in the Antibiotic Stewardship of Cystic Fibrosis Patients. Journal of Allergy and Clinical Immunology. 2020 Feb 1; 145(2):ab167. Anstey AK, Kleinhenz KM, Otani OI. .
      View in: Publisher Site   Mentions:
    47. Primary Immunodeficiency Diagnoses seen in Patients with Chronic Lung Disease: Findings from the USIDNET Registry. Journal of Allergy and Clinical Immunology. 2020 Feb 1; 145(2):ab178. Lee LM, Routes RJ, Marsh MR, Fuleihan FR, Lugar LP, Cunningham-Rundles CC, Garabedian GE, Otani OI. .
      View in: Publisher Site   Mentions:
    48. Hypogammaglobulinemia in Patients with Neuromyelitis Optica (NMO). Journal of Allergy and Clinical Immunology. 2020 Feb 1; 145(2):ab215. Tsao TL, Bove BR, Krishnakumar KT, Otani OI. .
      View in: Publisher Site   Mentions:
    49. A006 ADVERSE DRUG REACTIONS IN CYSTIC FIBROSIS PATIENTS: USING DATA TO DEVELOP AN ANTIBIOTIC EVALUATION PROGRAM. Annals of Allergy Asthma & Immunology. 2019 Nov 1; 123(5):s4. Anstey AK, Kleinhenz KM, Otani OI. .
      View in: Publisher Site   Mentions:
    50. 2543. Implementation of a Fellow-Driven ?-Lactam Allergy De-Labeling Initiative on an Inpatient ID Consult Service. Open Forum Infectious Diseases. 2019 Oct 23; 6(Supplement_2):s883-s883. Mulliken MJ, Bystritsky BR, Anstey AK, Otani OI, Doernberg DS. .
      View in: Publisher Site   Mentions:
    51. Strategies for Discontinuing Omalizumab in Patients with Chronic Urticaria: Real-World Findings. Journal of Allergy and Clinical Immunology. 2019 Feb 1; 143(2):ab302. Seghezzo SS, Tsao TL, Otani OI. .
      View in: Publisher Site   Mentions:
    52. Perioperative Use and Safety of Cephalosporin Antibiotics in Patients with Documented Penicillin Allergy. Journal of Allergy and Clinical Immunology. 2019 Feb 1; 143(2):ab29. Anstey AK, Anstey AJ, Hilts-Horeczko HA, Doernberg DS, Chen CL, Otani OI. .
      View in: Publisher Site   Mentions:
    53. Beta-lactam Administration Patterns at a Safety-net Hospital with Limited Access to Inpatient Penicillin Skin Testing. Journal of Allergy and Clinical Immunology. 2019 Feb 1; 143(2):ab31. Song SP, Hwa HM, Eng EJ, Otani OI. .
      View in: Publisher Site   Mentions:
    54. Hypogammaglobulinemia in Multiple Sclerosis Patients Receiving Disease-Modifying Immunomodulatory Agents. Journal of Allergy and Clinical Immunology. 2019 Feb 1; 143(2):ab16. Tsao TL, Otani OI, Bove BR. .
      View in: Publisher Site   Mentions:
    55. Development of a health-related quality of life instrument for patients with hereditary angioedema living in the United States. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1679-1683.e7. Busse PJ, Christiansen SC, Birmingham JM, Overbey JR, Banerji A, Otani IM, Lumry W, Goryachkovsky A, Zuraw BL. PMID: 30550806.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    56. Diffuse cutaneous mastocytosis with novel somatic KIT mutation K509I and association with tuberous sclerosis. Clin Case Rep. 2018 Sep; 6(9):1834-1840. Otani IM, Carroll RW, Yager P, Kroshinsky D, Murphy S, Hornick JL, Akin C, Castells M, Walter JE. PMID: 30214774; PMCID: PMC6132108.
      View in: PubMed   Mentions: 7  
    57. Cutaneous Manifestations of Reactions to Biologics. Curr Allergy Asthma Rep. 2018 02 21; 18(2):12. Otani IM, Levin AS, Banerji A. PMID: 29464437.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    58. Impact of a Novel Radiocontrast Media Reaction Treatment Algorithm in Simulation Settings of Anaphylaxis. Journal of Allergy and Clinical Immunology. 2018 Feb 1; 141(2):ab34. Otani OI, Otrakji OA, Holtzman HN, Iandoli IM, Blumenthal BK, Banerji BA, Salazar SG. .
      View in: Publisher Site   Mentions:
    59. Documentation of Adverse Drug Reactions in Electronic Medical Records: Areas for Improvement and Impact on Clinical Outcomes. Journal of Allergy and Clinical Immunology. 2018 Feb 1; 141(2):ab168. Nguyen NJ, Otani OI. .
      View in: Publisher Site   Mentions:
    60. Chapter 23 Corticosteroids. Drug Allergy Testing. 2018 Jan 1; 261-268. Otani OI. .
      View in: Publisher Site   Mentions:
    61. Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1266-1273.e2. Otani IM, Lax T, Long AA, Slawski BR, Camargo CA, Banerji A. PMID: 28986119.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    62. Platinum Chemotherapy Hypersensitivity: Prevalence and Management. Immunol Allergy Clin North Am. 2017 11; 37(4):663-677. Otani IM, Wong J, Banerji A. PMID: 28965633.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    63. Acquired C1 Inhibitor Deficiency. Immunol Allergy Clin North Am. 2017 08; 37(3):497-511. Otani IM, Banerji A. PMID: 28687105.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    64. Biologic Therapies for Immunoglobulin E-mediated Food Allergy and Eosinophilic Esophagitis. Immunol Allergy Clin North Am. 2017 05; 37(2):369-396. Otani IM, Nadeau KC. PMID: 28366483.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    65. Gastrointestinal Manifestations in X-linked Agammaglobulinemia. J Clin Immunol. 2017 Apr; 37(3):287-294. Barmettler S, Otani IM, Minhas J, Abraham RS, Chang Y, Dorsey MJ, Ballas ZK, Bonilla FA, Ochs HD, Walter JE. PMID: 28236219; PMCID: PMC5414010.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    66. Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility. J Allergy Clin Immunol Pract. 2017 Mar - Apr; 5(2):442-447.e1. Otani IM, Lumry WR, Hurwitz S, Li HH, Craig TJ, Holtzman NS, Iandoli MI, Tucker J, Riedl MA, Zuraw BL, Banerji A. PMID: 27818136.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):128-134.e4. Otani IM, Christiansen SC, Busse P, Camargo CA, Zuraw BL, Riedl MA, Banerji A. PMID: 27665386.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    68. Reactions to Rituximab in an Outpatient Infusion Center: A 5-Year Review. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):107-113.e1. Levin AS, Otani IM, Lax T, Hochberg E, Banerji A. PMID: 27497683.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    69. Immediate and Delayed Hypersensitivity Reactions to Corticosteroids: Evaluation and Management. Curr Allergy Asthma Rep. 2016 Mar; 16(3):18. Otani IM, Banerji A. PMID: 26857016.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    70. Immediate and Delayed Hypersensitivity Reactions to Proton Pump Inhibitors: Evaluation and Management. Curr Allergy Asthma Rep. 2016 Mar; 16(3):17. Otani IM, Banerji A. PMID: 26810177.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    71. Subcutaneous Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema: Comparison of Self-Administration to Administration at a Medical Facility. Journal of Allergy and Clinical Immunology. 2016 Feb 1; 137(2):ab250. Otani OI, Lumry LW, Li LH, Chase CC, Craig CT, Riedl RM, Zuraw ZB, Banerji BA. .
      View in: Publisher Site   Mentions:
    72. A role for vancomycin epicutaneous skin testing in the evaluation of perioperative anaphylaxis. J Allergy Clin Immunol Pract. 2015 Nov-Dec; 3(6):984-5. Otani IM, Kuhlen JL, Blumenthal KG, Guyer A, Banerji A. PMID: 26246124; PMCID: PMC4641770.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    73. Two year effects of food allergen immunotherapy on quality of life in caregivers of children with food allergies. Allergy Asthma Clin Immunol. 2014; 10(1):57. Arasi S, Otani IM, Klingbeil E, Bégin P, Kearney C, Dominguez TL, Block WM, O'Riordan G, Nadeau KC. PMID: 25788951; PMCID: PMC4363059.
      View in: PubMed   Mentions: 20  
    74. Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects. Allergy Asthma Clin Immunol. 2014; 10(1):25. Otani IM, Bégin P, Kearney C, Dominguez TL, Mehrotra A, Bacal LR, Wilson S, Nadeau K. PMID: 24860608; PMCID: PMC4032627.
      View in: PubMed   Mentions: 29  
    75. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2013 Jun; 131(6):1576-82. Otani IM, Anilkumar AA, Newbury RO, Bhagat M, Beppu LY, Dohil R, Broide DH, Aceves SS. PMID: 23623266; PMCID: PMC3699422.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    76. Multi-Allergen Oral Immunotherapy Improves Quality of Life in Subjects with Food Allergies. Journal of Allergy and Clinical Immunology. 2013 Feb 1; 131(2):ab58. Otani OI, Dominguez DT, Sciancalepore SA, Mehrotra MA, Pineda PD, Nadeau NK. .
      View in: Publisher Site   Mentions:
    77. The Effect of Anti-IL-5 Therapy on Esophageal Mastocytosis in Pediatric Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology. 2012 Feb 1; 129(2):ab202. Otani OI, Bhagat BM, Newbury NR, Dohil DR, Broide BD, Aceves AS. .
      View in: Publisher Site   Mentions:
    78. Monomeric IgE and mast cell development, survival and function. Adv Exp Med Biol. 2011; 716:29-46. Kashiwakura J, Otani IM, Kawakami T. PMID: 21713650.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    79. A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohort. Genet Med. 2007 Jul; 9(7):413-26. Putcha GV, Bejjani BA, Bleoo S, Booker JK, Carey JC, Carson N, Das S, Dempsey MA, Gastier-Foster JM, Greinwald JH, Hoffmann ML, Jeng LJ, Kenna MA, Khababa I, Lilley M, Mao R, Muralidharan K, Otani IM, Rehm HL, Schaefer F, Seltzer WK, Spector EB, Springer MA, Weck KE, Wenstrup RJ, Withrow S, Wu BL, Zariwala MA, Schrijver I. PMID: 17666888.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    80. Enhancement of IGE-induced mediator release from rat peritoneal mast cells by serum-treated zymosan. Cell Immunol. 1984 Sep; 87(2):400-10. Otani I, Conrad DH, Ruddy S. PMID: 6205769.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    81. [Renal disease in the nail-patella syndrome: report of an affected family and studies of renal disease susceptibility and HLA (author's transl)]. Nihon Jinzo Gakkai Shi. 1978 Aug; 20(8):909-20. Kuroda M, Akiyama T, Otani I, Kusunoki N, Tohfuku Y, Imura M, Tamai T, Takeda R. PMID: 713167.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Iris's Networks
    Concepts (185)
    Derived automatically from this person's publications.
    _
    Co-Authors (28)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _